Literature DB >> 19908336

Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.

Krzysztof Fyderek1, Magdalena Strus, Kinga Kowalska-Duplaga, Tomasz Gosiewski, Andrzej Wedrychowicz, Urszula Jedynak-Wasowicz, Małgorzata Sładek, Stanisław Pieczarkowski, Paweł Adamski, Piotr Kochan, Piotr B Heczko.   

Abstract

AIM: To assess the mucosa-associated bacterial microflora and mucus layer in adolescents with inflammatory bowel disease (IBD).
METHODS: Sixty-one adolescents (mean age 15 years, SD+/-4.13) were included in the study. Intestinal biopsies from inflamed and non-inflamed mucosa of IBD patients and from controls with functional abdominal pain were cultured under aerobic and anaerobic conditions. The number of microbes belonging to the same group was calculated per weight of collected tissue. The mucus thickness in frozen samples was measured under a fluorescent microscope.
RESULTS: The ratios of different bacterial groups in inflamed and non-inflamed mucosa of IBD patients and controls were specific for particular diseases. Streptococcus spp. were predominant in the inflamed mucosa of Crohn's disease (CD) patients (80% of all bacteria), and Lactobacillus spp. were predominant in ulcerative colitis patients (90%). The differences were statistically significant (P=0.01-0.001). Lower number of bifidobacteria was observed in the whole IBD group. A relation was also found between clinical and endoscopic severity and decreased numbers of Lactobacillus and, to a lesser extent, of Streptococcus in biopsies from CD patients. The mucus layer in the inflamed sites was significantly thinner as compared to controls (P=0.0033) and to non-inflamed areas in IBD patients (P=0.031).
CONCLUSION: The significantly thinner mucosa of IBD patients showed a predominance of some aerobes specific for particular diseases, their numbers decreased in relation to higher clinical and endoscopic activity of the disease.

Entities:  

Mesh:

Year:  2009        PMID: 19908336      PMCID: PMC2776855          DOI: 10.3748/wjg.15.5287

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  [MUC genes: mucin or not mucin? That is the question].

Authors:  Nicole Porchet; Jean-Pierre Aubert
Journal:  Med Sci (Paris)       Date:  2004-05       Impact factor: 0.818

2.  Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis.

Authors:  Margarita Martinez-Medina; Xavier Aldeguer; Ferran Gonzalez-Huix; Doroteo Acero; L Jesús Garcia-Gil
Journal:  Inflamm Bowel Dis       Date:  2006-12       Impact factor: 5.325

3.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 4.  Molecular analysis of the intestinal microflora in IBD.

Authors:  G W Tannock
Journal:  Mucosal Immunol       Date:  2008-11       Impact factor: 7.313

5.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  Changes of viability and composition of the Escherichia coli flora in faecal samples during long time storage.

Authors:  S J Achá; I Kühn; G Mbazima; Patricia Colque-Navarro; R Möllby
Journal:  J Microbiol Methods       Date:  2005-06-24       Impact factor: 2.363

7.  Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.

Authors:  Shadi Sepehri; Roman Kotlowski; Charles N Bernstein; Denis O Krause
Journal:  Inflamm Bowel Dis       Date:  2007-06       Impact factor: 5.325

Review 8.  Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshimi Benno; Osamu Kanauchi; Yoshihide Fujiyama
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Adhesion of commensal bacteria to the large intestine wall in humans.

Authors:  C L Hartley; C S Neumann; M H Richmond
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

10.  Immunoreactivity against Goblet cells in patients with inflammatory bowel disease.

Authors:  Brita Ardesjö; Guida M Portela-Gomes; Fredrik Rorsman; Eva Gerdin; Lars Lööf; Lars Grimelius; Olle Kämpe; Olov Ekwall
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

View more
  48 in total

1.  An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants.

Authors:  Jenny K Gustafsson; Anna Ermund; Malin E V Johansson; André Schütte; Gunnar C Hansson; Henrik Sjövall
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-08       Impact factor: 4.052

2.  Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.

Authors:  Misagh Alipour; Deenaz Zaidi; Rosica Valcheva; Juan Jovel; Inés Martínez; Consolato Sergi; Jens Walter; Andrew L Mason; Gane Ka-Shu Wong; Levinus A Dieleman; Matthew W Carroll; Hien Q Huynh; Eytan Wine
Journal:  J Crohns Colitis       Date:  2015-12-09       Impact factor: 9.071

3.  Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota.

Authors:  Philip Smith; Jay Siddharth; Ruth Pearson; Nicholas Holway; Mark Shaxted; Matt Butler; Natalie Clark; Joanna Jamontt; Robert P Watson; Devika Sanmugalingam; Scott J Parkinson
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

Review 4.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

5.  Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.

Authors:  Min Xu; Baohong Wang; Yiqi Fu; Yanfei Chen; Fengling Yang; Haifeng Lu; Yunbo Chen; Jiali Xu; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-08-04       Impact factor: 4.552

6.  Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.

Authors:  Sunaina Rengarajan; Emily E Vivio; Miles Parkes; Daniel A Peterson; Elisha D O Roberson; Rodney D Newberry; Matthew A Ciorba; Chyi-Song Hsieh
Journal:  Gut Microbes       Date:  2019-06-16

Review 7.  An integrative view of microbiome-host interactions in inflammatory bowel diseases.

Authors:  Marta Wlodarska; Aleksandar D Kostic; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

Review 8.  Nutritional protective mechanisms against gut inflammation.

Authors:  Monica Viladomiu; Raquel Hontecillas; Lijuan Yuan; Pinyi Lu; Josep Bassaganya-Riera
Journal:  J Nutr Biochem       Date:  2013-03-27       Impact factor: 6.048

Review 9.  Mucosal healing and deep remission: what does it mean?

Authors:  Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

10.  Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions.

Authors:  Rodrigo Bibiloni; Eduardo J Schiffrin
Journal:  Int J Inflam       Date:  2010-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.